Evaluation of population‐level pharmacogenetic actionability in Alabama
Abstract The evolution of evidence and availability of Clinical Pharmacogenetic Implementation Consortium (CPIC) guidelines have enabled assessment of pharmacogenetic (PGx) actionability and clinical implementation. However, population‐level actionability is not well‐characterized. We leveraged the...
Saved in:
Main Authors: | Brittney H. Davis (Author), Kelly Williams (Author), Devin Absher (Author), Bruce Korf (Author), Nita A. Limdi (Author) |
---|---|
Format: | Book |
Published: |
Wiley,
2021-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Pharmacogenetic actionability and medication prescribing in people with cystic fibrosis
by: Justin D. Anderson, et al.
Published: (2023) -
Warfarin Pharmacogenetics: Challenges and Opportunities for Clinical Translation
by: Nita A Limdi, et al.
Published: (2012) -
Politics of Alabama
by: Manning, Joseph C. (Joseph Columbus), 1870- -
Validation of the Spartan RXCYP2C19 Genotyping Assay Utilizing Blood Samples
by: Brittney H. Davis, et al.
Published: (2020) -
The Story of the Kearsarge and Alabama
by: Browne, A. K.